Aegros

Aegros company information, Employees & Contact Information

Explore related pages

Related company profiles:

At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege. Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process. Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma. Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG) Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.

Company Details

Employees
65
Founded
-
Address
5 Eden Park Drive, Macquarie Park,nsw 2113,australia
Phone
+61 29-856-3500
Email
in****@****.com.au
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Macquarie Park, NSW
Looking for a particular Aegros employee's phone or email?

Aegros Questions

News

Sydney biotech company folds months after $37m raised - The Courier Mail

Sydney biotech company folds months after $37m raised The Courier Mail

Biotech start-up raising $20m pre-IPO amid missed payment claims - AFR

Biotech start-up raising $20m pre-IPO amid missed payment claims AFR

Aegros’ HaemaFrac plasma fraction process offers new defence against COVID-19 and other diseases - smallcaps.com.au

Aegros’ HaemaFrac plasma fraction process offers new defence against COVID-19 and other diseases smallcaps.com.au

Blood BioTech Aegros to build $352m manufacturing hub in Qld - InnovationAus.com

Blood BioTech Aegros to build $352m manufacturing hub in Qld InnovationAus.com

CSL challenger Aegros to build Singapore plasma plant - The Australian

CSL challenger Aegros to build Singapore plasma plant The Australian

The Royal Group, Fresh Start Australia, and Aegros Forge $400M Plasma Fragmentation Facility in ASEAN, Bolstering Cambodia's Healthcare Industry - Cambodia Investment Review

The Royal Group, Fresh Start Australia, and Aegros Forge $400M Plasma Fragmentation Facility in ASEAN, Bolstering Cambodia's Healthcare Industry Cambodia Investment Review

Bio-Med Company to Build $352m Facility in Qld Precinct - The Urban Developer

Bio-Med Company to Build $352m Facility in Qld Precinct The Urban Developer

Royal Group, Australian companies form JV for plasma fragmentation - Khmer Times

Royal Group, Australian companies form JV for plasma fragmentation Khmer Times

Blood biotech Aegros chases $300m-plus float, raising first - AFR

Blood biotech Aegros chases $300m-plus float, raising first AFR

A challenger appears: Could this new entrant threaten the CSL share price? - The Motley Fool Australia

A challenger appears: Could this new entrant threaten the CSL share price? The Motley Fool Australia

Meet the company planning to challenge CSL’s monopoly - The Australian

Meet the company planning to challenge CSL’s monopoly The Australian

Blood pressure rises at Aegros, the next plasma hopeful - AFR

Blood pressure rises at Aegros, the next plasma hopeful AFR

Plasma trial to boost immunity for health workers - The Australian

Plasma trial to boost immunity for health workers The Australian

Top Aegros Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant